. Author manuscript; available in PMC: 2013 Jun 30.

Published in final edited form as: Nitric Oxide. 2012 Mar 14;27(1):1–8. doi: 10.1016/j.niox.2012.02.004

Table 1.

Effect of monocrotaline (MCT) and sodium nitrite treatment on pulmonary and systemic hemodynamic values.

	PAP, Systolic (mmHg)	PAP, Diastolic (mmHg)	PAP mean (mmHg)	PVR (mmHg/ml/min)	MAP (mmHg)	Cardiac Output (ml/min)	SVR (mmHg/ml/min)
Control	30 ± 2	9 ± 1	20 ± 0	0.18 ± 0.01	110 ± 5	105 ± 6	0.99 ± 0.07
MCT	86 ± 7^*	29 ± 4^*	54 ± 2^*	0.55 ± 0.04^*	99 ± 6	103 ± 7	1.06 ± 0.05
MCT +NaNO₂ 3mg/kg	42 ± 1^*^⧧	21 ± 3^*^⧧	33 ± 3^*^⧧	0.31 ± 0.02^*^⧧	99 ± 5	92 ± 7	0.93 ± 0.04

Values are expressed as mean ± SE.

denotes a P value < 0.05 when compared to control,

^⧧

denotes a P value < 0.05 when compared to MCT n = 11, 9, and 11 for Control, monocrotlaine, and monocrotaline+ NaNO₂ groups respectively.

PAP pulmonary arterial pressure, PVR pulmonary vascular resistance, MAP mean arterial pressure, SVR systemic vascular resistance.

Control rats received a saline injection via tail vein on day one. MCT rats received ip saline injections on day 14–35 as a control for ip NaNO₂ injections.